Information
More articles below:
New Risk Factors for Colon Cancer Studied
Many Doctors Not Using Colon Cancer Test Properly
Better Treatment Found for Crohn's Disease
Gulf War Syndrome Is Real, But Causes Unclear
You Are What Microbes You Eat
Blacks Less Likely to Get Follow-Up Colon Screening
Zenpep Approved for Pancreatic Disorder
FRIDAY, Aug. 28 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zenpep (pancrelipase) delayed-release capsules to treat a pancreatic disorder that prevents people from properly digesting food, Dutch drug maker Eurand NV said.
Exocrine pancreatic insufficiency (EPI) is caused by a lack of digestive enzymes produced by the pancreas, a possible symptom of conditions including cystic fibrosis and pancreatic cancer.
Zenpep was approved in different strengths for adults and children as young as a year old, Eurand said in a news release. It's expected to be available at U.S. pharmacies later this year.
The most common adverse reactions reported during clinical testing of Zenpep included gastrointestinal problems, abdominal pain, headache, cough and loss of weight, the company said.
More information
Learn more about this drug's approval history from the FDA.
DON'T HAVE Rx COVERAGE?Click Here to print out your FREE OPTIMIZERx Card and instantly begin savings on your next prescriptions!
